Literature DB >> 10331601

Postmortem examination of two fragile X brothers with an FMR1 full mutation.

E Reyniers1, J J Martin, P Cras, E Van Marck, I Handig, H Z Jorens, B A Oostra, R F Kooy, P J Willems.   

Abstract

Large expansions of the CGG repeat in the 5' untranslated region of the FMR1 gene are found in patients with the fragile X syndrome. Amplified CGG repeats in FMR1 are unstable and show intergenerational increase from mother to offspring. The exact timing of repeat amplification, however, is unknown. We have compared the extent of CGG expansion in various tissues of this deceased fragile X patient, and found only limited variation in repeat expansion. The repeat was fully methylated in all tissues examined. Therefore, no evidence for extensive mitotic expansion of the CGG repeat during fetal or postnatal life of a fragile X patient was found, in contrast to dynamic mutations caused by CAG/CTG repeat expansion. Extensive pathological examination of this patient and his affected brother revealed no evidence for specific abnormalities relevant to fragile X syndrome; cerebellar hypoplasia, which has been reported in this disorder, was not evident in either patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331601     DOI: 10.1002/(sici)1096-8628(19990528)84:3<245::aid-ajmg16>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

Review 1.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

2.  The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2015-04       Impact factor: 4.878

3.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.

Authors:  Arturo López Castel; Masayuki Nakamori; Stephanie Tomé; David Chitayat; Geneviève Gourdon; Charles A Thornton; Christopher E Pearson
Journal:  Hum Mol Genet       Date:  2010-11-01       Impact factor: 6.150

Review 4.  Synaptic regulation of protein synthesis and the fragile X protein.

Authors:  W T Greenough; A Y Klintsova; S A Irwin; R Galvez; K E Bates; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.

Authors:  J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

6.  Role of replication and CpG methylation in fragile X syndrome CGG deletions in primate cells.

Authors:  Kerrie Nichol Edamura; Michelle R Leonard; Christopher E Pearson
Journal:  Am J Hum Genet       Date:  2004-12-29       Impact factor: 11.025

Review 7.  Mechanisms of the FMR1 Repeat Instability: How Does the CGG Sequence Expand?

Authors:  Elisabetta Tabolacci; Veronica Nobile; Cecilia Pucci; Pietro Chiurazzi
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

8.  The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells.

Authors:  Jeannine Gerhardt; Mark J Tomishima; Nikica Zaninovic; Dilek Colak; Zi Yan; Qiansheng Zhan; Zev Rosenwaks; Samie R Jaffrey; Carl L Schildkraut
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

9.  The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.

Authors:  Samantha Portis; Brian Giunta; Demian Obregon; Jun Tan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

Review 10.  Instability and chromatin structure of expanded trinucleotide repeats.

Authors:  Vincent Dion; John H Wilson
Journal:  Trends Genet       Date:  2009-06-18       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.